All Three Proxy Advisors Back Genesco's Board in Activist Fight
GCO sits 62% above its 52-week low of $21.545 on light trading volume (0.1× avg).
Summary
Genesco announced that all three independent proxy advisory firms—ISS, Glass Lewis, and Egan-Jones—recommend shareholders vote FOR the company's nine director nominees, dealing a blow to activist Bradley Radoff's proxy fight.
Key Events · Corporate Governance and Compliance · GCO
-
Unanimous Proxy Advisor Support
ISS, Glass Lewis, and Egan-Jones all recommend voting FOR Genesco's nine director nominees on the WHITE proxy card, rejecting activist Bradley Radoff's two nominees.
-
Glass Lewis Critique of Activist
Glass Lewis stated the dissident 'has not presented a comprehensive and compelling case for change' and noted Genesco's 'reasonably favorable course' under CEO Mimi Vaughn.
-
Egan-Jones Endorsement
Egan-Jones concluded shareholders should vote for management, citing 'recovering cash flow, modestly improving profitability, and early evidence of successful Journeys repositioning.'
-
Annual Meeting Set for July 21
Shareholders will vote at the 2026 Annual Meeting on July 21, 2026; the company urges voting on the WHITE proxy card.
Analysis · GCO · Trade & Services
Ahead of the July 21 annual meeting, Genesco has secured unanimous support from ISS, Glass Lewis, and Egan-Jones for its nine director nominees—a pivotal turn in the proxy contest with activist Bradley Radoff, who holds an 8.7% stake. The recommendations directly undercut the activist's case for change: Glass Lewis stated the dissident 'has not presented a comprehensive and compelling case,' while Egan-Jones cited improving fundamentals. This unified backing from the advisory firms substantially increases the likelihood that shareholders will vote for the company's slate, preserving the current board and strategy.
At the time of this filing, GCO was trading at $34.89 on NYSE in the Trade & Services sector, with a market capitalization of approximately $387.5M. The 52-week trading range was $21.55 to $43.60. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.